A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

This study tests a drug called SHR3680 (a type of androgen receptor blocker) given before surgery in men with high-risk localized prostate cancer, to see if it improves outcomes compared to surgery alone. **You may be eligible if...** - You are 18 or older with a confirmed diagnosis of prostate cancer (adenocarcinoma) - Your cancer is classified as high-risk and has not spread to other organs (no distant metastases) - You are scheduled to have radical prostatectomy (complete prostate removal with lymph node dissection) - You have received little or no prior treatment for prostate cancer **You may NOT be eligible if...** - You have received significant prior prostate cancer treatment (other than short-term hormone therapy or androgen blockers for up to 4 weeks) - Your cancer has spread to distant organs - You have had major surgery or another investigational drug within 4 weeks of the study Talk to your doctor to see if this trial is right for you.